Prodoc AI Raises Seed Round Led by Velumani Family Office | VeilStrat

Prodoc AI Closes Seed Round

Prodoc AI, a Bengaluru-based healthcare AI company, has raised a Seed round led by Velumani Family Office. Additional investors include Kunal Shet and Parth D. Bhasin. The funding date is September 30, 2026. The funding amount was not disclosed.

What Prodoc AI Does

Prodoc AI builds a Patient Journey OS for hospitals. Its FHIR-native platform layers an intelligence system over existing HIS, EMR, CRM, billing, telephony, and diagnostics tools. The platform coordinates patient acquisition, appointment conversion, OPD operations, care coordination, and follow-ups without replacing current infrastructure.

Founded in 2022 and led by co-founder and CEO Asit Kumar Vidyarthi with COO Raghuvamshi Thakur, Prodoc AI runs in over 100 Indian hospitals and processes more than one million patient engagements monthly.

The Opportunity

Hospitals often operate with a patchwork of systems for patient management, billing, and communications. Prodoc AI's approach is to sit on top of these existing tools rather than replace them, using FHIR-native interoperability to unify patient data and automate workflows across the care journey. This positions the company to serve hospitals seeking operational efficiency without a full system overhaul.

Funding Details

Round type: Seed
Lead investor: Velumani Family Office
Additional investors: Kunal Shet, Parth D. Bhasin
Funding date: September 30, 2026
Amount: Not disclosed

Acquisition Relevance

For acquirers in healthcare IT, hospital operations software, or AI-driven patient engagement, Prodoc AI offers a deployed platform with measurable scale: over 100 Indian hospitals and more than one million patient engagements per month. The FHIR-native architecture may ease integration with existing hospital systems, reducing post-acquisition technical friction.

The Seed round, led by Velumani Family Office with participation from Kunal Shet and Parth D. Bhasin, provides capital to expand the company's footprint in the Indian hospital market. Strategic buyers looking for a patient journey orchestration layer that complements rather than replaces incumbent HIS and EMR systems may find Prodoc AI relevant.